Artificial Intelligence in Ocular Oncology: Differentiating Choroidal Melanocytic Lesions

This article explores the application of artificial intelligence (AI) in the differentiation of choroidal melanocytic lesions, specifically choroidal nevi and small melanomas, within the field of ocular oncology. The primary topic highlights the significance of accurately diagnosing these lesions to enhance patient outcomes and management strategies.

The study reviews of the role of AI in differentiating choroidal melanocytic lesions, particularly choroidal nevi from small melanomas, examining clinical and imaging risk factors. It explores deep learning (DL) applications for image classification and assesses AI's potential impact on patient care, diagnostic accuracy, and regulatory concerns in ocular oncology.

To achieve this, the methods discussed in this paper revolve around employing DL techniques, which utilize artificial neural networks to analyze high-dimensional medical images. This approach enables automated classification and image analysis of ophthalmic data, allowing for the identification of intricate patterns and features that may be imperceptible to clinicians. Additionally, the text reviews existing clinical and imaging risk factors associated with the growth of choroidal nevi into melanoma, leveraging this information to inform and enhance AI algorithms.

The anticipated results of integrating AI into clinical practice include increased diagnostic accuracy, which can lead to earlier identification of high-risk lesions and, consequently, timely interventions. This proactive approach has the potential to improve patient care significantly by facilitating better management strategies, thus enhancing patient outcomes. Artificial intelligence may also uncover subtle imaging features that would otherwise be overlooked, providing a more comprehensive assessment of lesions.

In conclusion, the paper emphasizes the transformative potential of AI in ocular oncology, advocating for its integration with existing imaging technologies. While AI offers promising advancements in diagnostic practices and patient care, the paper also acknowledges the necessity of addressing regulatory and implementation challenges to fully harness these benefits. Overall, the incorporation of AI technologies into the diagnostic workflow has the potential to not only save vision but also improve survival rates, marking a significant step forward in the management of choroidal melanocytic lesions.

Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.